Interpretation of regulatory factors for 3D printing at hospitals and medical centers, or at the point of care
Tóm tắt
3D printing is revolutionizing the medical device landscape through its ability to rapidly create patient-specific anatomic models, surgical instruments, and implants. Recent advances in 3D printing technology have allowed for the creation of point-of-care (PoC) 3D printing centers. These PoC centers blur the line between healthcare provider, medical center, and device manufacturer, creating regulatory ambiguity. The United States Food & Drug Administration (FDA) currently regulates 3D printed devices through existing medical device regulations. However, the FDA is increasingly interested in developing guidelines and regulations specifically for PoC 3D printing due to its rapid adoption across the healthcare institutions. In this article, we review the regulatory framework that governs medical devices, discuss how PoC 3D printing falls within this framework, and describe a novel conceptual framework that the FDA has proposed. Finally, through analysis of the aforementioned regulations and discussions with industry medical 3D printing regulatory experts, we provide recommendations for PoC medical 3D printing best practices so that institutions are best positioned to utilize this revolutionary technology safely and effectively.
Tài liệu tham khảo
Bagaria V, Chaudhary K. A paradigm shift in surgical planning and simulation using 3Dgraphy: Experience of first 50 surgeries done using 3D-printed biomodels. Injury. 2017;48(11):2501–8.
Chi-Kay L, King-him C, Kin-bong L, Wilson L. Computer-Assisted Planning and Three-Dimensional-Printed Patient-Specific Instrumental Guide for Corrective Osteotomy in Post-Traumatic Femur Deformity: A Case Report and Literature Review. J Orthop Trauma Rehabil. 2018. doi:https://doi.org/10.1016/j.jotr.2016.11.002.
Lin CY, Wirtz T, LaMarca F, Hollister SJ. Structural and mechanical evaluations of a topology optimized titanium interbody fusion cage fabricated by selective laser melting process. J Biomed Mater Res A. 2007;83(2):272–9.
Koeck FX, Beckmann J, Luring C, Rath B, Grifka J, Basad E. Evaluation of implant position and knee alignment after patient-specific unicompartmental knee arthroplasty. Knee. 2011;18(5):294–9.
Di Prima M, Coburn J, Hwang D, Kelly J, Khairuzzaman A, Ricles L. Additively manufactured medical products - the FDA perspective. 3D Print Med. 2016. doi:https://doi.org/10.1186/s41205-016-0005-9.
Technical Considerations for Additive Manufactured Medical Devices. https://www.fda.gov/media/97633/download. Accessed 14 December 2021.
Arce K, Morris JM, Alexander AE, Ettinger KS. Developing a Point-of-Care Manufacturing Program for Craniomaxillofacial Surgery. Atlas Oral Maxillofac Surg Clin North Am. 2020;28(2):165–79.
Medical Manufacturing Innovations. Physicians as Manufacturers. https://www.sme.org/globalassets/sme.org/media/white-papers-and-reports/3d_printing_fuels_the_rise.pdf. Accessed 14 December 2021.
American Society of Mechanical Engineers (ASME). 3D Printing at the Point of Care. https://resources.asme.org/poc3dp-events. Accessed 14 December 2021.
3D Printing in Drug Development & Emerging Health Care. https://www.fda.gov/media/125479/download. Accessed 14 December 2021.
Classify Your Medical Device. https://www.fda.gov/medical-devices/overview-device-regulation/classify-your-medical-device. Accessed 14 December 2021.
General Controls for Medical Devices. https://www.fda.gov/medical-devices/regulatory-controls/general-controls-medical-devices#QSR. Accessed 14 December 2021.
De Novo Classification Request. https://www.fda.gov/medical-devices/premarket-submissions/de-novo-classification-request. Accessed 26 December 2021.
FDA/CDRH–RSNA SIG Joint Meeting on 3D Printed Patient-Specific Anatomic Models, August 31. 2017. https://wayback.archive-it.org/7993/20201222130156/https://www.fda.gov/medical-devices/workshops-conferences-medical-devices/fdacdrh-rsna-sig-joint-meeting-3d-printed-patient-specific-anatomic-models-august-31-2017. Accessed 14 December 2021.
Mitsouras D, Liacouras P, Imanzadeh A, Giannopoulos AA, Cai T, Kumamaru KK, George E, Wake N, Caterson EJ, Pomahac B, Ho VB, Grant GT, Rybicki FJ. Medical 3D Printing for the Radiologist. Radiographics. 2015;35:1965–88.
Mitsouras D, Liacouras PC, Wake N, Rybicki FJ. RadioGraphics Update: Medical 3D Printing for the Radiologist. Radiographics. 2020;40(4):E21–3.
Christensen A, Rybicki FJ. Maintaining safety and efficacy for 3D printing in medicine. 3D Print Med. 2017. doi:https://doi.org/10.1186/s41205-016-0009-5.
Content of Premarket Submissions for Management of Cybersecurity in Medical Devices. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/content-premarket-submissions-management-cybersecurity-medical-devices-0. Accessed 14 December 2021.
Chepelev L, Wake N, Ryan J, Althobaity W, Gupta A, Arribas E, et al. Radiological Society of North America (RSNA) 3D printing Special Interest Group (SIG): guidelines for medical 3D printing and appropriateness for clinical scenarios. 3D Print Med. 2018;4(1):11.
Use of International Standard ISO 10993-1. “Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process.“ https://www.fda.gov/regulatory-information/search-fda-guidance-documents/use-international-standard-iso-10993-1-biological-evaluation-medical-devices-part-1-evaluation-and. Accessed 14 December 2021.
Schulze M, Gosheger G, Bockholt S, De Vaal M, Budny T, Tönnemann M, Pützler J, Bövingloh AS, Rischen R, Hofbauer V, et al. Complex Bone Tumors of the Trunk—The Role of 3D Printing and Navigation in Tumor Orthopedics: A Case Series and Review of the Literature. J Pers Med. 2021. doi:https://doi.org/10.3390/jpm11060517.
Discussion Paper. 3D Printing Medical Devices at the Point of Care. https://www.fda.gov/medical-devices/3d-printing-medical-devices/3d-printing-medical-devices-point-care-discussion-paper. Accessed 17 January 2022.